National Institute of Allergy and Infectious Diseases, National Institutes of Health
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID

NIAID Research Funding

NIAID Funding News
Opportunities and Announcements
Budget and Funding
Grant Portals
Application
Peer Review
Grant Award and Management

Early-Stage Investigator

Training and Career
R01 Investigator Resources
International Awards
Small Business Awards
Other Grant Types

Animals in Research

Human Subjects and Clinical Research
Biodefense and Biosecurity
Contracts Portal
Standard Operating Procedures
Questions and Answers
Advisory Council
Glossary of Funding and Policy Terms
Find It! A-Z
Latest Updates
Search in Research Funding

This timeline tells you what to expect for fiscal year 2009. Other application types use different receipt dates; check NIH's Standard Due Dates for Competing Applications. For initiative receipt dates, see the funding opportunity announcement.

Application Steps

Date

Review Cycle 1
Review Cycle 2
Review Cycle 3

1. Prepare application. Get advice from NIAID's All About Grants and mentors.

Depends on grant type, investigator experience, other factors. Depends on grant type, investigator experience, other factors. Depends on grant type, investigator experience, other factors.

2. Organization submits the application.

Leave enough time to make corrections.

The application goes to Grants.gov and then eRA Commons for validation.

New non-AIDS applications:
By February 5, 2008

All AIDS applications:
By May 7, 2008

Resubmissions,
non-AIDS:
By March 5, 2008

New non-AIDS applications:
By June 5, 2008

All AIDS applications:
By September 8, 2008

Resubmissions,
non-AIDS:
By July 7, 2008

New non-AIDS applications:
By October 5, 2008

All AIDS applications:
By January 7, 2009

Resubmissions,
non-AIDS:
By November 5, 2008

Submission
Review Cycle 1
Review Cycle 2
Review Cycle 3

3. Receipt date is the deadline.

NIH has three standard receipt dates for R01 applications.

New non-AIDS applications:
February 5, 2008

All AIDS applications:
May 7, 2008

Resubmissions,
non-AIDS:
March 5, 2008

New non-AIDS applications:
June 5, 2008

All AIDS applications:
September 8, 2008

Resubmissions,
non-AIDS:
July 7, 2008

New non-AIDS applications:
October 5, 2008

All AIDS applications:
January 7, 2009

Resubmissions,
non-AIDS:
November 5, 2008

Review
Review Cycle 1
Review Cycle 2
Review Cycle 3

4. Assignment. Find the institute and integrated review group in Commons.

Within two weeks

Within two weeks

Within two weeks

5. NIH assigns applications to reviewers. May 2008 September 2008 January 2009

6. Applications undergo initial peer review. Find priority scores in the Commons five days after initial peer review.

Find summary statements six to eight weeks later, sooner for new investigators.

June or
July 2008

October or November 2008 February or
March 2009
After Review
Review Cycle 1
Review Cycle 2
Review Cycle 3

7. NIAID begins to fund applications that undergo expedited second-level review.

Starting in October 1, 2008* Starting in November 2008 Starting in March 2009

8. NIAID Council approves funding for selective pay and non-expedited applications.

September 15, 2008

January 26, 2009

May 18, 2009

9. NIAID funds selective pay and non-expedited awards.

These are the earliest project start dates. Some applications are deferred for possible funding later in the fiscal year.

December 2008 through end of fiscal year April 2009
through end of fiscal year
July 2009
through end of fiscal year
10. End of fiscal year. Fiscal year 2009 ends on September 30, 2009.

* For step 7, expedited review for cycle 1 occurs toward the end of the fiscal year; however, by law, NIAID cannot fund applications until the next fiscal year.

For more resources and advice, see the Application Tools for All About Grants.

Separator line
DHHS Logo Department of Health and Human Services NIH Logo National Institutes of Health NIAID Logo National Institute of Allergy and Infectious Diseases April 16, 2008
Home | Help | Site Index | Accessibility | Privacy Policy | Disclaimer | Web Site Links & Policies | FOIA